Publicaciones en colaboración con investigadores/as de University of Texas at Austin (5)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

2020

  1. Hyperprogression and Immunotherapy: Fact, Fiction, or Alternative Fact?

    Trends in Cancer, Vol. 6, Núm. 3, pp. 181-191

2013

  1. Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia

    Nature Genetics, Vol. 45, Núm. 2, pp. 186-190

2002

  1. Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma

    Blood, Vol. 99, Núm. 4, pp. 1474-1477